Minimal inhibitory concentrations for canine isolates and oral absorption of roxythromycin in fed and fasted dogs.
Lavy
E
E
Koret School of Veterinary Medicine, Hebrew University of Jerusalem, Rehovot, Israel.
Ziv
G
G
Shem-Tov
M
M
Glickman
A
A
D000284:Administration, Oral; D000818:Animals; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology; D001682:Biological Availability; D004285:Dogs / Q000378:metabolism* / Q000382:microbiology; D004435:Eating / Q000502:physiology*; D004917:Erythromycin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics / Q000494:pharmacology; D005215:Fasting / Q000502:physiology*; D005260:Female; D018565:Food-Drug Interactions; D006094:Gram-Positive Bacteria / Q000187:drug effects; D007408:Intestinal Absorption; D008297:Male; D008826:Microbial Sensitivity Tests / Q000662:veterinary; D015575:Roxithromycin / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D015575:Roxithromycin; D004917:Erythromycin